Last reviewed · How we verify

NCT07581093

The REACT Study: REhabilitation and ACTivity in Allogenic Transplant

Not yet recruiting
What this trial tests

trial in Allogeneic Hematopoietic Stem Cell Transplant (Allo-HSCT) in 140 participants. Not yet recruiting.

Timeline
1 May 2026
28 December 2029

Quick facts

Lead sponsorUniversity of Dublin, Trinity College
StatusNot yet recruiting
Enrollment140
Start date1 May 2026
Estimated completion28 December 2029

Conditions studied

Sponsor

University of Dublin, Trinity College

Who can join

Eligibility, any sex, with Allogeneic Hematopoietic Stem Cell Transplant (Allo-HSCT).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University of Dublin, Trinity College trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07581093.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing